The serum levels of DKK-1 are significantly higher in patients with active RA than in healthy controls [15], and the change in the DDK-1 levels may serve as a biomarker of disease activity and radiographic progression [9,15,36]. This evidence concerns the gene MGME1 and rheumatoid arthritis.